| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 120/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Miltefosine |
| Appearance | White Powder |
| CAS NO. | 58066-85-6 |
| Molecular Formula | C21H46NO4P |
| Storage | Keep in a cool, dry, dark location |
Miltefosine, with the molecular formula C21H46NO4P, is an alkylphosphocholine drug originally developed as an anti-tumor agent. It possesses cell membrane targeting properties and has been shown to exhibit significant selective anti-tumor and anti-protozoal activities in both animal experiments and clinical applications.
Anti-Tumor Treatment: Miltefosine is primarily used for the local treatment of epidermal metastases of breast cancer, particularly in cases where conventional therapies have been ineffective.
Anti-Protozoal Therapy: It is also employed in the treatment of cutaneous and visceral leishmaniasis, demonstrating good efficacy and low toxicity compared to traditional antiprotozoal drugs.
Alternative Medicine: Miltefosine offers a new therapeutic option for patients with recurrent or refractory epidermal metastatic breast cancer, providing potential improvements in quality of life and disease stabilization.
Cell Membrane Targeting: Miltefosine's structure resembles the phospholipid components of the cell membrane, allowing it to enter cancer cells and induce a special functional disorder that prevents tumor growth.
Immunomodulatory Activity: It promotes IL-2 mediation and induces T cell activation, suggesting a potential role in modulating the immune system and enhancing the body's response to cancer.
Selective Anti-Tumor Activity: Miltefosine has a strong inhibitory effect on hormone-dependent breast cancer but shows no activity against hormone-independent cell line tumors, highlighting its selective anti-tumor properties.
){kind=link}